<div id="readability-page-1"><div><p><span>HKEX: </span></p><ul><li>BLACKROCK'S LONG POSITION IN H-SHARES OF WUXI APPTEC  DECREASES TO 4.51% ON FEB 16 FROM 5.22%</li></ul></div></div>

02359

516930

<p>HKEX: BLACKROCK'S LONG POSITION IN H-SHARES OF WUXI APPTEC DECREASES TO 4.51% ON FEB 16 FROM 5.22%</p>

Reuters

BlackRock

WUXI APPTEC

Minsheng Royal CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

SPDR S&P Biotech

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

WuXi Biologics

ChinaAMC SSE STAR Biology and Medicine ETF

iShares Biotechnology ETF

HKEX

ChinaAMC CSI Biotechnology Theme ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Bosera Hang Seng Health Care ETF(QDII)

Hwabao WP CSI Pharmaceuticals ETF

VanEck Biotech ETF

Penghua CSI HK Connect Health Care Composite ETF

Huaan Hang Seng Biotech ETF

Penghua SSE STAR Biology and Medicine ETF

Guotai CSI Bio-medicine ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

Yinhua CSI Innovative Drugs Industry ETF

Hong Kong Exchanges and Clearing (HKEX)

E Fund CSI Biotechnology Theme ETF

Tianhong CNI BIOMEDICINE ETF

Blackrock's Long Position In H-Shares Of WuXi AppTec Decreases To 4.51% On Feb 16 From 5.22%, HKEX Shows